TruAlt Bioenergy Limited TruAlt Bioenergy Limited has announced the cessation of Yagati Badarinarayana Ramakrishna from his roles as Independent Director and Chairman, effective July 28, 2026. The change in board composition stems from regulatory requirements limiting independent directors to two consecutive terms. Consequently, Mr. Ramakrishna also ceases to be a member of the Corporate Social Responsibility (CSR) Committee with immediate effect.

The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing ensures transparency regarding changes in the board’s composition and adherence to corporate governance norms set by the Securities and Exchange Board of India.

Regulatory Compliance and Term Limits

Under the SEBI Listing Regulations, independent directors are permitted to serve for a maximum of two consecutive terms. Upon completing this tenure, they must undergo a cooling-off period before being eligible for reappointment. TruAlt Bioenergy Limited confirmed that Mr. Ramakrishna has completed his second consecutive term, necessitating his exit from the board to maintain compliance.

Monu Kumar, Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, signed the intimation letter dated July 28, 2026. The company stated that the relevant details have been made available on its official website for stakeholder reference.

Details of Cessation

The following table outlines the specific details of the director's cessation as reported in the filing:

Governance Implications

The departure of an independent director and chairman requires the board to manage the transition of responsibilities within the existing committee structures. While the filing does not name a successor, the cessation is a routine governance event driven by statutory term limits rather than performance or dispute. Investors should note that the company remains compliant with all listing obligations during this transition period.

Trualt Bioenergy will host an earnings conference call for investors and analysts on July 29, 2026, at 11:00 AM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. The event provides stakeholders with direct access to the management team for insights into the company's performance in Q1FY27. This disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call is scheduled to begin with a presentation by the management team, followed by a question-and-answer session. TruAlt Bioenergy Limited filed the intimation with both the Bombay Stock Exchange and the National Stock Exchange of India Limited on July 24, 2026. Monu Kumar, Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, signed the disclosure. The company noted that the schedule is subject to change due to exigencies on the part of the investors or the company.

Participants can join the call via dial-in numbers provided for domestic and international access. The audio recording and transcript of the conference call will be made available on the company's website at www.trualtbioenergy.com after the event. Investors are required to register using the provided Diamond Pass registration link to participate.

Dial-In Details

TruAlt Bioenergy Limited operates as India's largest ethanol producer by installed capacity. The company's portfolio includes ethanol, compressed bio gas (CBG), and upcoming ventures in second-generation (2G) ethanol, sustainable aviation fuel (SAF), and allied biochemicals. The business aligns with government initiatives such as the National Biofuels Policy 2018, the Ethanol Blending Program, and the SATAT scheme.

What This Means for Investors

The earnings call serves as a primary channel for transparency regarding the company's financial health and strategic direction for Q1FY27. While specific financial metrics such as net profit, revenue, or EBITDA were not disclosed in this intimation, the subsequent discussion will likely cover operational updates and future outlooks related to its clean energy transition strategy. Investors should monitor the company's website for the post-call transcript and recording for detailed financial analysis.